Columnist Sam Kirton explains when the new FDA-approved IPF treatment Jascayd might be made available to patients.
Guest writer Kylene Henderson recalls the lengthy journey she and her husband faced to get answers and a pulmonary fibrosis diagnosis.
Long-term treatment with deupirfenidone (LYT-100) is generally well tolerated and may stabilize lung function in people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback